The St. Louis Cardinals have put together an impressive showing during the early part of the 2026 season, exceeding many expectations and even placing themselves in the conversation for a potential postseason run. However, despite their strong performance so far, the organization’s overall direction suggests that they could lean toward selling pieces at the trade deadline rather than aggressively adding talent.
This is largely because the current season is still viewed as part of a broader rebuilding phase. While the team’s fast start has generated excitement, there is also a realistic understanding within the organization that such momentum may not be sustainable over the course of a full season.
If that early surge begins to fade and the club slips in the standings, the front office led by Chaim Bloom would likely pivot toward making moves that prioritize long-term success over short-term gains.
In that type of scenario, the Cardinals would not hesitate to explore trading players who currently hold value, even if they are popular within the clubhouse or fan base. One such player who has recently been mentioned in trade speculation is outfielder Lars Nootbaar. Known for his energy, versatility, and on-base ability, Nootbaar has become a fan favorite in St. Louis, making the idea of a potential trade somewhat surprising on the surface.
Still, according to reporting from Robert Murray of FanSided, Nootbaar is among the players who could emerge as trade candidates ahead of the deadline—but only under certain conditions. (Sporting News)
The first major factor involves his current health and availability. Nootbaar has yet to take the field this season, which presents a significant obstacle for any potential deal.
MORE: Cardinals ‘Will Certainly’ Cut Ties With Veteran Pitcher
Teams are unlikely to commit meaningful assets for a player who has not demonstrated that he is fully healthy and capable of contributing at a high level. Until he returns and proves he can perform, his trade value remains somewhat uncertain. That alone creates a substantial hurdle that would need to be cleared before serious trade discussions could gain traction.
Even though he hasn’t played yet in 2026, Nootbaar still holds appeal across the league. Over the course of his career, he has shown the ability to get on base consistently and contribute in multiple ways, including defensive flexibility across the outfield.
His overall offensive profile, highlighted by a respectable OPS, makes him an attractive option for teams looking to strengthen their lineup. (Sporting News) However, without recent on-field performance, interested clubs may be hesitant to meet a high asking price.
That brings up the second key condition: the Cardinals’ demands in a potential trade. Bloom has a reputation for being calculated and disciplined when it comes to roster decisions, and he is unlikely to move a player like Nootbaar unless the return package meets or exceeds the organization’s expectations. In other words, even if Nootbaar proves he is healthy and resumes playing well, a trade would only happen if another team is willing to offer significant value in return.
This combination of factors creates a narrow pathway for a deal to materialize. First, Nootbaar must demonstrate that he is fully recovered and capable of performing at his usual level. Then, there must be a team willing to meet what could be a relatively steep price set by the Cardinals’ front office. Without both of those elements aligning, it is far more likely that he would remain in St. Louis.
Another important aspect to consider is the overall market dynamics leading up to the trade deadline. If the Cardinals do decide to sell, they will not be the only team doing so.
MORE: Cardinals Make Another Crucial Roster Move
However, the number of buyers often outweighs the number of sellers, which can drive up demand for players who offer versatility and upside—qualities that Nootbaar possesses. In such a market, the Cardinals could find themselves in a strong negotiating position, further reinforcing their willingness to hold firm on their asking price.
At the same time, Nootbaar’s popularity and potential long-term value to the team cannot be ignored. He is not simply a short-term rental or expendable piece; he has multiple years of team control remaining and could still be part of the Cardinals’ future plans. That reality makes any decision involving him more complex. Trading a player with that profile would likely require a return that significantly strengthens the organization’s long-term outlook.
Ultimately, while the Cardinals’ strong start has opened the door to postseason aspirations, their broader rebuilding strategy suggests that selling remains a very real possibility. If the team begins to regress and falls out of serious contention, Bloom and the front office will almost certainly explore opportunities to move valuable assets.
Nootbaar stands out as an intriguing but conditional trade candidate. His potential availability hinges on both his ability to return to form and the willingness of another team to meet the Cardinals’ demands. Until those two hurdles are cleared, any speculation about a deal remains just that—speculation.
For now, the situation reflects the delicate balance the Cardinals must strike between competing in the present and building for the future. Whether they ultimately choose to hold onto Nootbaar or include him in a larger strategy of roster reshaping will depend on how the season unfolds and how the market develops in the weeks leading up to the trade deadline.
Cardinals could trade Lars Nootbaar if two things happen
Robert Murray expressed some uncertainty about whether Lars Nootbaar will even be made available on the trade market, but he made it clear that the outfielder is expected to attract significant attention from other teams if the Cardinals choose to listen to offers. Even if St. Louis does not actively shop him, his profile as a controllable, productive outfielder makes him the type of player that rival clubs will naturally inquire about.
Murray emphasized that Nootbaar is not scheduled to reach free agency until after the 2027 season, which means any team acquiring him would gain multiple seasons of control. Because of that added value, the Cardinals would almost certainly set a steep asking price. Still, if Nootbaar proves he is healthy and performing at a high level again, it is entirely plausible that a team could decide he is worth the cost and step forward with a strong offer.
In essence, there are two primary obstacles that would need to be overcome for a trade involving Nootbaar to materialize—beyond the obvious requirement that other teams must be interested in acquiring him. The first is his recovery from injury, and the second is the substantial price tag that president of baseball operations Chaim Bloom is likely to demand in return.
MORE: Braves to trade for Giants’ $90M superstar Ace to pair with Chris Sale
The health factor is particularly significant. Nootbaar is currently working his way back from a serious offseason procedure, having undergone surgery on both heels to address lingering issues. (MLB.com) This type of injury is not insignificant, especially for an outfielder whose game relies on mobility, agility, and the ability to move effectively both in the field and on the basepaths. As a result, he has yet to appear in a Major League game during the 2026 season, which creates a layer of uncertainty around his current condition and performance level.
From a trade perspective, that uncertainty presents a major complication. Teams are generally hesitant to part with valuable assets for a player who has not yet taken the field in the current season. Without recent game action, there is no clear way to evaluate how well Nootbaar has recovered or whether he can return to his previous form. Medical reports and rehab updates can provide some reassurance, but they are not a substitute for actual in-game production. (SI)
Even if a front office believes in Nootbaar’s long-term ability, committing to a trade without seeing him perform carries a level of risk that many organizations may be unwilling to accept. It is one thing to like a player’s track record, but it is another to invest in him without current evidence that he is fully healthy and capable of contributing right away. That gap between potential and proof is one of the biggest hurdles standing in the way of any deal.
That said, Nootbaar’s overall body of work still makes him an appealing target. Over the course of his career, he has demonstrated the ability to be a productive offensive player, posting a .747 OPS and showing a knack for getting on base.
MORE: It’s Painfully Obvious What’s Going On With Diamondbacks’ All-Star Hitter Ketel Marte Right Now
Those qualities, combined with his defensive versatility across the outfield, make him an attractive option for teams in need of a well-rounded contributor. Players with that type of profile are always in demand, particularly at the trade deadline when contenders are looking to strengthen their rosters for a postseason push.
Because of this, interest in Nootbaar is expected to exist regardless of whether he has played yet in 2026. Teams can look at his past performance and project what he might bring if he returns to form. However, projecting potential is very different from confirming it, and that distinction is what makes his situation so complex.
The injury-related uncertainty is only one side of the equation. Even if Nootbaar successfully returns to action and demonstrates that he is healthy, there is still the matter of what it would take to acquire him. Bloom is known for taking a disciplined and calculated approach to roster management, and he is unlikely to move a player of Nootbaar’s caliber without receiving a significant return.
At 28 years old, Nootbaar is in what is typically considered the prime of his career. In addition, he remains under team control through the 2027 season, meaning any acquiring team would not be renting him for a short-term push but would instead gain multiple seasons of value. That combination—prime age, proven ability, and extended control greatly enhances his trade value.
Because of that, the Cardinals would have little incentive to settle for anything less than a strong package of prospects or major league-ready talent. For a potential trade partner, that creates a second major hurdle. Not only must they be comfortable with Nootbaar’s health, but they must also be willing to meet what could be a very high asking price.
This is where the situation becomes particularly challenging. Even if a team is intrigued by Nootbaar and believes in his upside, there is a limit to how much risk they are willing to take. If his medical situation remains uncertain, teams may be reluctant to part with top-tier prospects. On the other hand, if the Cardinals insist on a premium return, negotiations could stall unless Nootbaar clearly proves his value on the field.
Timing will likely play a crucial role in determining whether a deal ultimately comes together. As the trade deadline approaches, teams will have a better understanding of both their own needs and Nootbaar’s condition. If he is able to return, perform well, and demonstrate that his injury is no longer a concern, his value could rise quickly. In that case, the Cardinals might find themselves fielding multiple offers, potentially creating a competitive market for his services.
On the flip side, if questions about his health persist or if his performance is inconsistent after returning, teams may hesitate to meet the Cardinals’ demands. That could result in St. Louis holding onto him, either with the intention of keeping him long-term or revisiting trade discussions at a later date when his value is more clearly established.
Ultimately, the possibility of a Nootbaar trade hinges on a delicate balance between risk and reward for both sides. For the Cardinals, the decision involves determining whether the return they could receive now outweighs the value of keeping a controllable outfielder who could still be part of their future. For potential suitors, the challenge lies in deciding whether Nootbaar’s upside justifies the combination of health-related uncertainty and the likely high acquisition cost.
If everything aligns if Nootbaar returns to full strength, performs at a high level, and a team is willing to meet Bloom’s asking price then a trade becomes a very real possibility. However, until those conditions are met, the idea of moving him remains uncertain.
In the end, while Nootbaar is undoubtedly a player who will draw interest across the league, the path to an actual deal is far from straightforward. It requires both his health concerns to be resolved and a trade partner willing to make a significant investment. Only if those two hurdles are cleared will the Cardinals seriously consider parting with one of their most recognizable and well-liked players.
Be the first to comment